Literature DB >> 23050655

Partial laryngopharyngectomy in the treatment of squamous cell carcinoma of hypopharynx: analysis of the oncologic results and laryngeal preservation rate.

Yen-Ling Kuo1, Chia-Fan Chang, Shyne-Yih Chang, Pen-Yuan Chu.   

Abstract

CONCLUSION: Partial laryngopharyngectomy (PLP) provides acceptable oncologic results and laryngeal preservation rate in selected patients with squamous cell carcinoma of the hypopharynx. Even when local recurrence develops, the chance of successful salvage is still high.
OBJECTIVES: To evaluate the oncologic results and laryngeal preservation rate in patients with squamous cell carcinoma of the hypopharynx who underwent PLP.
METHODS: The results of 39 patients who underwent PLP were compared with those of 91 patients who underwent total laryngectomy (TL).
RESULTS: The distribution of the primary T stages were 23 (59%) pT2, 9 (23%) pT3, and 7 (18%) pT4; the pathologic stages were 8 patients (21%) stage II, 9 (23%) stage III, and 22 (56%) stage IV. All of the patients also had ipsilateral or bilateral neck dissections. Eighteen patients (46%) received postoperative adjuvant therapy. After a median follow-up of 39 months, 17 patients (44%) had recurrence, including 12 local, 2 regional, and 3 distant lesions. The 5-year overall and disease-specific survival were 44% and 56%, respectively; functional preservation was 62%. The recurrence rate was similar in patients treated with PLP and TL (44% vs 36%, p = 0.431); the local recurrence rate was higher after PLP than after TL (31% vs 8%, p = 0.001). The salvage surgery was successful in four of the six patients (67%). After salvage treatment, the 5-year overall survival (44% vs 47%) and disease-specific survival (56% vs 62%) were similar in the two groups.

Entities:  

Mesh:

Year:  2012        PMID: 23050655     DOI: 10.3109/00016489.2012.700122

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.

Authors:  Jun Won Kim; Mi Sun Kim; Se-Heon Kim; Joo Hang Kim; Chang Geol Lee; Gwi Eon Kim; Ki Chang Keum
Journal:  Cancer Res Treat       Date:  2015-03-13       Impact factor: 4.679

2.  Clinicopathological factors influencing the outcomes of surgical treatment in patients with T4a hypopharyngeal cancer.

Authors:  Sang-Yeon Kim; Young-Soo Rho; Eun-Chang Choi; Min-Sik Kim; Joo-Hyun Woo; Dong Hoon Lee; Eun Jae Chung; Min Woo Park; Da-Hee Kim; Young-Hoon Joo
Journal:  BMC Cancer       Date:  2017-12-29       Impact factor: 4.430

3.  Use of Supraclavicular Flap by End to Side Technique in Pharyngeal SCC: A Case Report and Review of Literature.

Authors:  Aslan Ahmadi; Ayda Sanaei; Delaram Jan; Maryam Zolfaghary
Journal:  Case Rep Otolaryngol       Date:  2021-07-14

4.  The presence of risk factors and corresponding treatment strategies post-surgical resection in stage IV hypopharyngeal squamous cell carcinoma patients: a retrospective cohort study.

Authors:  Yu Heng; Xiaoke Zhu; Liang Zhou; Ming Zhang; Hong Zhou; Lei Tao
Journal:  Ann Transl Med       Date:  2020-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.